Mathew Easow Research Securities Share Price

SMS Pharma's Hyderabad facility completes USFDA inspection with 1 observation

Adani Enterprises arm incorporates wholly owned subsidiary in Dubai

Godrej Properties acquires 10 acres of land in Bengaluru for Rs 2,500 cr project

M&M to raise prices of SUV and CV range as input price pressures mount

ICRA reaffirms ratings of Data Patterns at 'A' with 'positive' outlook

1) UFR of the company for the qtr. and nine months ended 31st December 2024. Enclosed herewith a copy of the same along with a copy of LRR dated 12th February 2025 of GGPS & associates statutory of the company with respect to UFR for the aforesaid period.2) Non applicability of statement of deviation(s) or variation(s) under Regulation 32 of SEBI Regulation 2015

day of February 2025 considered and approved inter-alia the following business;1) Unaudited Financial Results of the Company for the quarter and nine months ended 31st December 2024. Enclosed herewith a copy of the same along with a copy of Limited Review Report dated 12th February 2025 of M/s. GGPS & Associates Statutory Auditors of the Company with respect to Unaudited Financial Results for the aforesaid period.2) Further please find attached undertaking regarding Non-Applicability of Statement of Deviation(s) or Variation(s) under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.Meeting was commenced at 1:00 P.M.(IST)Meeting was concluded at 1:40 P.M (IST)This is for your information and records.

MATHEW EASOW RESEARCH SECURITIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday the 12th day of February 2025 at the Registered Office of the Company to transact inter-alia to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended 31st December 2024.As informed and in terms of provisions of SEBI (Prohibition of Insider trading) Regulations 2015 and the Companys Insiders Trading Code of Conduct the Trading Window for dealing in the securities of the Company will be closed to all Directors / Connected / Designated Persons till 48 hours after the declaration of the aforesaid Unaudited Financial Results.

In compliance with Regulation 74(5) of SEBI Regulation 2018 we enclosing herewith a copy of the certificate received from M/s. MCS Transfer Agent Limited the registrar and share Transfer Agent of the Company for the quarter ended 31st december 2024.

This is to inform that pursuant to SEBI Regulation 2015 as amended the trading window for dealing in the securities of the company will be closed to all the directors from 1st january 2025 till 48 hours after the declaration of the Unaudited Financial Results of the Company for the Quarter and Nine months ended on 31st December 2024. Accordingly all Directors / connected/ Designated Persons of the Company are advised not to trade on the securities of the company during the trading window closure period.